openPR Logo
Press release

What's driving the Ventricular Assist Devices Market 2025? Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic

03-13-2020 11:14 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Study Report LLC

What's driving the Ventricular Assist Devices Market 2025?

U.S. ventricular assist devices market is estimated to show robust CAGR of around 5.0% over the forecast timeframe. As per the American College of Cardiology, around 800,000 people in the U.S. die due to cardiovascular diseases. Growing prevalence of CVD diseases, adoption of sedentary lifestyle, increasing heart failure rate among the population and recent technological advancements are some of the major market driving factors in the country.

The Ventricular Assist Devices Market study now available with Market Study Report, LLC, is a collation of valuable insights related to market share, profitability margin, growth dynamics and regional proliferation of this business vertical. The study further includes a detailed analysis pertaining to key challenges, growth opportunities and application segments of the Ventricular Assist Devices Market.

Request a sample of this premium report titled Ventricular Assist Devices Market 2019 - 2025 at https://www.marketstudyreport.com/request-a-sample/1357103?utm_source=openpr.com&utm_medium=Ram

Some of the leading players in the ventricular assist devices market include Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic, Terumo Corporation and others. These companies focus on strategic decisions such as partnerships and collaborations to expand their product portfolio and capitalize on market opportunities. Additionally, inorganic strategies such as mergers and acquisitions help in company?s geographical expansion.

Ventricular assist devices market is expected to exceed USD 3.5 billion by 2025. Increasing number of heart failure cases across the globe, technological developments in ventricular assist devices and shortage of heart donors will boost ventricular assist devices market growth over the analysis timeframe.

Rise in awareness about the technological developments and use of ventricular assist devices in heart failure treatment will primarily drive industry growth in the near future. Growing mortality rates and surge in hospitalizations in the Latin America region due to high prevalence of heart failure will escalate the ventricular assist devices industry expansion. Moreover, lack of heart donors across the globe will serve to be another major market boosting factor. According to NCBI, the number of heart donations is expected to decrease in the near future and heart failure prevalence is estimated to increase multifold. Such factors will increase the demand for ventricular assist devices, thereby fueling the market growth.

Request a discount on standard prices of this premium report titled Ventricular Assist Devices Market 2019 - 2025 at https://www.marketstudyreport.com/check-for-discount/1357103?utm_source=openpr.com&utm_medium=Ram

Some major findings of the ventricular assist devices market report include:
- Increase in number of people suffering from heart failure and other cardiovascular diseases across the globe will serve to be one of the major impact rendering factors in the ventricular assist devices market growth
- Adoption of ventricular assist devices is increasing on account of technological advancement in these devices and its widespread application in the treatment of heart failure
- North America ventricular assist devices market held the maximum revenue share in the year 2018 owing to the factors including presence of major industry players, growing incidence of heart failure, accessibility to state-of-the-art healthcare facilities, favorable reimbursement policies and insurance coverage
- Companies operating in ventricular assist devices market resort to strategic collaborations, mergers & acquisitions to strengthen their market position

Ventricular assist devices are extremely complicated and critical devices that are used in the treatment of end-stage heart failure. These devices require strict medical rules and regulations that are needed to be followed by the manufacturers. Hence, stringent regulations pertaining to ventricular assist devices may hamper business growth in the near future.

Bridge-to-transplant (BTT) therapy market is estimated to show substantial CAGR of more than 5.5% during the forecast period. As per the American Heart Association (AHA) journal, BTT-VAD therapy is associated with increase in patient?s survival rate and cost-effectiveness of the treatment. Thus, accessibility to such affordable therapies will increase the adoption of these devices in the low- and middle-income countries, thereby fueling business growth during the upcoming years.

Percutaneous ventricular assist devices (PVADs) segment held around USD 1 billion revenue in the year 2018. Increase in number of right ventricle failure rates has led to surge in the adoption of PVADs over the recent years. Several benefits of PVADs such as safety, ease of implantation and high reliability for survival will prove beneficial for the market progress.

The sales of ventricular assist devices in the people aged between 40-59 years of age accounted for over USD 900 million in 2018. Growing prevalence of heart failure among the people between 40-59 years of age will serve as a major factors that will spur ventricular assist devices market over the analysis period.

Continuous flow ventricular assist devices market is estimated to witness more than 6% growth over the forecast timeframe. Wide usage of these devices in the patients requiring mechanical circulatory support as destination and bridge-to-transplant therapy for end-stage heart failure will favor segment growth. Aforementioned factors are projected to play a significant role in augmenting the industry growth.

Implantable ventricular assist devices segment is poised to exceed USD 2.5 billion by 2025. The implantable ventricular assist devices are mechanical pumps that are implanted inside the patient body. These devices enable pumping of blood from lower chambers of the heart to the rest of your body. Hence, surge in number of people suffering from end-stage congestive heart failure (HF) and requiring external mechanical support will further boost the adoption of implantable ventricular assist devices.

Report Content

Chapter 1. Methodology

Chapter 2. Executive Summary

Chapter 3. Ventricular Assist Devices Industry Insights

Chapter 4. Ventricular Assist Devices Market, By Product

Chapter 5. Ventricular Assist Devices Market, By Application

Chapter 6. Ventricular Assist Devices Market, By Age

Chapter 7. Ventricular Assist Devices Market, By Flow

Chapter 8. Ventricular Assist Devices Market, By Design

Chapter 9. Ventricular Assist Devices Market, By Region

Chapter 10. Company Profiles

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975

USA

Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com

Website: https://www.marketstudyreport.com

Blog: https://www.marketstudyreport.com/blog

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Ventricular Assist Devices Market 2025? Abbott, Abiomed, Berlin Heart, Bivacor, CardiacAssist, Inc., Evaheart, Maquet, Jarvik Heart, Medtronic here

News-ID: 1967212 • Views: 224

More Releases from Market Study Report LLC

What's driving the Small Satellite Market trends? Raytheon, Lockheed Martin, Nor …
Market Study Report LLC adds new research on Small Satellite market, which is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysis, application potential, and the regional growth landscape, Small Satellite market also includes an in-depth study of the industry competitive scenario. The global Small Satellite market is valued at 1340 million US$ in 2018
What's driving the Antibiotics Market trends? Sanofi, Novartis AG, Pfizer Inc., …
Market Study Report LLC has added a new report on Antibiotics market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Antibiotics market in tandem with its competitive terrain. The antibiotics was valued at US$ 43,348.38 million in 2019 and is
What's driving the Electrical House (E-House) Market trends? Schneider Electric, …
Market Study Report LLC has added a new report on Electrical House (E-House) market that provides a comprehensive review of this industry with respect to the driving forces influencing the market size. Comprising the current and future trends defining the dynamics of this industry vertical, this report also incorporates the regional landscape of Electrical House (E-House) market in tandem with its competitive terrain. Electrical House (E-House), also called Power House, is
What's driving the Hub Motors Market trends? ZF Friedrichshafen, Siemens, Protea …
Market Study Report LLC adds new research on Hub Motors market, which is a detailed analysis of this business space inclusive of the trends, competitive landscape, and the market size. Encompassing one or more parameters among product analysis, application potential, and the regional growth landscape, Hub Motors market also includes an in-depth study of the industry competitive scenario. The Hub Motors market report provides a detailed analysis of global market size,

All 5 Releases


More Releases for Ventricular

Latest Evolution of Ventricular Drainage Sets Market Analysis 2026
Ventricular Drainage Sets Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Ventricular Drainage Sets market research report is a professional and in-depth study on the current state of Ventricular Drainage Sets Industry. The Ventricular Drainage Sets Market research report covers the present scenario and
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction Overview Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction. Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018 Top Companies mentioned Bayer AG Innopharmax Inc Mesoblast Ltd Novartis AG Quantum Genomics SA TiGenix NV Left Ventricular Dysfunction Industry Major Outlook Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -
Ventricular Tachycardia Market Forecast Report Offers Actionable Insights 2017 - …
Ventricular tachycardia is a condition, wherein the pulse rate is more than 100 beats per minute with minimum three continuous irregular heartbeats. This condition occurs in bottom chambers of the heart and develops as an early or late complication of heart attack. Patients suffering from cardiomyopathy, myocarditis, or valvular heart disease are at a higher risk of developing ventricular tachycardia. Major reasons for ventricular tachycardia are changes in pH values,
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease. Report Highlights Publisher's Pharmaceutical and Healthcare
Ventricular Tachycardia Treatment Market And Segment Forecasts To 2017 – 2025
Ventricular tachycardia is a life threatening heart condition in which arrhythmic heart beats occur in the ventricles. The two lower chambers of the heart are known as ventricles. They are responsible for supplying the blood received from atria to different parts of the body. When a person suffers from ventricular tachycardia, a high pulse with more than 100 beats per minute is registered with minimum 3 irregular heartbeats experienced in
05-08-2017 | Health & Medicine
SA-BRC
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major